Replies to post #22007 on Omni Health Inc (OMHE)

[goodibag]

Marijuana_is_legal_for_medical_use_in_29_states_OMHE_is_Working_On_MMJ_FDA_Approval
Twenty-nine states and Washington, DC, allow marijuana for medical purposes, although their approaches can significantly differ.

Some allow medical marijuana dispensaries and home cultivation. Others only allow home cultivation. And a few allow dispensaries but not home cultivation.

In 2018 more states will legalize Medical Marijuana.

At least 12 states are poised to consider marijuana legalization this year, with more possibly joining as legislative sessions continue, making 2018 a potentially pivotal year in the burgeoning bud movement. Some states are even preparing to take unprecedented legislative steps to make marijuana—either recreational or medical—legal and more easily accessible.

"With over 60 percent of Americans now supporting the full legalization of marijuana for adults, the momentum behind marijuana law reform will not only continue but increase as we head into 2018," Erik Altieri, executive director for the National Organization for the Reform of Marijuana Laws, told Newsweek.

READ-HERE

OMHE@1c_Rev~$20Mil_FDAcbdMed_ShareRestruc_QBuplist_MMJcultivation_OvrTCntrCBD_NEXT

HERE is WHAT OMHE HAS ACCOMPLISHED SO FAR

(1) In Feb 2017 OMHE shared its vision and indicated its plan on working on therapeutic cannabis products and licensed medical marijuana cultivation.
CLICK HERE TO READ FEB 2017 OMHE VISION & FUTURE PLANS

(2) In My 2017 OMHE announced the opening of its Biotech R&D Lab.
CLICK HERE TO READ MAY 2017 LAB ANNOUNCEMENT

(3) In June 2017 Biotech scientists with FDA/regulatory approval joined OMHE.
CLICK HERE TO READ JUNE 2017 SCIENTISTS ANNOUNCEMENT

(4) In Nov 2017 OMHE updated about cannabinoid-based drug-development.
CLICK HERE TO READ NOV 2017 DRUG DEVELOPMENT UPDTE

(5) In Dec 2017 OMHE announced its plan already in motion to create a drug candidate compelling to Big Pharma, development of cannabidiol pain treatment therapeutic & medicine and filing of FDA registration by employing an FDA regulations-savvy, ‘fast-track’ pipeline strategy.
CLICK HERE TO READ DEC 2017 FDA REGISTRATION UPDATE

(6) In Dec 2017 OMHE announced launch of $7 million revenue generating Consumer Goods Division operating under subsidiary, Celebrity Brands Inc; plan of acquiring a number of consumer, revenue-generating brands, and by creating a platform for future acquisitions that scale the distribution of company’s existing brands; and first wholesale order is from Amerimark Direct for Celeb Cream – one of the Company’s innovative anti-aging products.
CLICK HERE TO READ DEC 2017 Consumer Goods Division ANNOUNCEMENT

(7) In Dec 2017 OMHE announced 3.7 Million Euro distribution agreement across Europe.
CLICK HERE TO READ DEC 2017 3.7 MILLION EURO DISTRIBUTION AGREEMENT